Words are, of course, the most powerful drug used by mankind. The first year of Annals of the Child Neurology Society (ACNS) has been marked by extraordinary progress, and we pause here to review and celebrate the journal's successful launch. As an official journal of the Child Neurology Society, ACNS offers a venue for clinical and translational research articles, clinically relevant basic science articles, patient reports, teaching vignettes, and quality improvement articles. It also provides a forum for discussion of important professional issues and factors that affect the care of children with neurological disease.1 The society maintains its traditional relationship with Annals of Neurology, with its focus on more basic research. Several years ago, the American Neurological Association created Annals of Clinical and Translational Neurology (ACTN), and the addition of ACNS by the Child Neurology Society forms an Annals “family” of journals that together support a wide range of scholarly endeavors. We have a great collaborative relationship with the editors of Annals of Neurology, and authors of manuscripts that cannot be accepted by Annals are offered consideration by ACNS or ACTN. We expect this transfer option to eventually become an important source of articles for ACNS. The first few months were spent building the journal's infrastructure. It takes considerable behind-the-scenes time and effort to create policies, websites, social media accounts, the editorial board, a detailed guide for authors, letter templates, and an initial reviewer database. ACNS features several innovative initiatives, including a monthly Editor's Choice article that is highlighted in an email to the society's members, a trainee mentoring program for novice writers, and ACNS Fast Track, a rapid review cycle designed to generate an initial publication decision within two weeks of submission. The first articles began to appear in December 2022.1 The initial ACNS articles have been remarkably good, led by a series of excellent review articles by pioneers in the field. The first article after the opening editorial was Harvey Sarnat's eloquent review of axonal pathfinding and guidance in the development of the nervous system, a basic science topic with obvious clinical relevance.2 Curtis Coughlin and Sidney Gospe contributed an outstanding summary of pyridoxine dependency.3 These authors were instrumental in unraveling the clinical features, genetics, and molecular mechanisms of pyridoxine dependency, so not surprisingly, their review is a tour de force. Nordli and Galan provide a detailed case-based review of magnetoencephalography, a valuable tool for identifying an epileptogenic zone and for pinpointing language, motor, and visual functions in relation to a brain lesion.4 Fernández and Peters provide an intriguing glimpse of potential clinical uses of artificial intelligence and algorithm-driven machine learning to process data and improve performance.5 The ACNS research articles have also been outstanding, although we cannot highlight all of them. Roberts and colleagues analyzed prospective observational data from 276 babies in their Neonatal Seizure Registry, concluding that inability to tolerate oral feedings by the time of discharge is associated with an increased risk of impaired development.6 This pattern was independent of gestational age, muscle tone at the time of hospital discharge, and abnormal electroencephalography. Zahl and colleagues took advantage of a long-standing detailed Swedish database of infants with suspected nonaccidental trauma to analyze 96 patients with a subdural hematoma.7 Males, prematurely born babies, and twins were overrepresented in the cohort. Their results should raise eyebrows: some 36% of the patients exhibited evidence of benign enlargement of the subarachnoid space associated with chronic subdural hematoma rather than abusive trauma. Trowbridge and colleagues analyzed the effect of seizure burden in neonates on later development in 84 neonates with an acute perinatal brain injury, 70% of whom experienced neonatal seizures.8 In babies with perinatal brain injury, higher neonatal seizure burden correlated with a worse developmental outcome, especially in individuals with an ischemic injury. Grose and Bonthius summarized 17 mostly immunocompetent patients with meningitis resulting from the varicella vaccine virus.9 Finally, ACNS provides a forum for discussion of professional challenges and the societal, economic, and cultural factors that affect the care of children with neurological diseases. Nina Schor, Deputy Director for Intramural Research at the NIH, provided an insider's guide to the opportunities for neuroscience training and career development at the NIH Intramural Research Program.10 A recent detailed analysis of child neurology training requirements generated a spirited discussion.11 Child neurology has a special position encompassing neurology, pediatrics, and developmental neuroscience, but the continued success of our discipline likely depends on how well we can adapt our training to include a stunning array of new discoveries and technological innovations. Since its founding in 1972, the Child Neurology Society's membership has increased dramatically and the needs of its members have become much more diverse. This is an amazingly productive time for the study of childhood neurological disorders, and the steady stream of exciting discoveries makes this an ideal time for the society to launch its clinically focused journal. While all new journals need time to grow and mature, at the one-year mark, ACNS is right on track. Its second year promises to be even better. E. Steve Roach: Conceptualization; project administration; writing—original draft; writing—review & editing. Phillip L. Pearl: Conceptualization; writing—review & editing. The opinions expressed in this article are those of the editors and do not reflect the official policy of the Child Neurology Society.